Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In Re: Pfizer Inc. Securities, Derivative & ERISA Litigation
Case Number:
1:05-md-01688
Court:
Nature of Suit:
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
- Abbey Spanier
- Brodsky Smith
- Cohen Milstein
- Emerson Poynter
- Faruqi & Faruqi
- Grant & Eisenhofer
- Harwood Feffer
- Horwitz Horwitz
- Kaplan Fox
- Law Office of Alfred G. Yates Jr.
- Law Offices of Curtis V. Trinko
- McConnell Valdes
- Reich & Binstock
- Robbins Geller
- Robbins LLP
- Squitieri & Fearon
- Stull Stull
- Wolf Haldenstein
Companies
Sectors & Industries:
-
May 26, 2015
2nd Circ. Asks How Expert Report Could Derail Pfizer Action
A Second Circuit panel wondered Tuesday how an extensively briefed securities fraud class action alleging Pfizer Inc. hid deadly risks associated with two painkillers could have been tossed on the eve of trial because of concerns over an economist's damages calculations, with two judges asking if less drastic measures would have sufficed.
-
March 23, 2012
Pfizer Can't Shake Fraud Suit Over Risky Arthritis Drugs
A New York federal judge refused Thursday to reconsider Pfizer Inc.'s bid to toss a putative class action securities fraud suit claiming it concealed studies showing heart attack risks associated with arthritis drugs Celebrex and Bextra.